We are live on
!
Find out more
MC
Mayo Clinic Portfolio holdings
AUM
$2.9M
1-Year Est. Return
14.49%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$67M
(-35%)
Cap. Flow
-$75.3M
Cap. Flow
% of AUM
-61.83%
Top 10 Holdings %
Top 10 Hldgs %
99.9%
Holding
14
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scilex Holding
SCLX
|
+$335K |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$96.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$75.5M |
| 2 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
+$267K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.77% |
| 2 | Energy | 8.29% |
| 3 | Healthcare | 5.84% |
| 4 | Financials | 0.09% |
Similar funds
SWS
PWA
CU
QC
SOA
HVM
JC
MIG
Mayo Clinic's Q1 2023 Portfolio in Review
As of Q1 2023, Mayo Clinic held 14 positions worth $122M, down 35% from $189M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mayo Clinic withdrew a net $75.3M in Q1 2023, closing 1 position and reducing 1 holding. Its most notable exit was Sorrento Therapeutics, Inc., an estimated $267K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 90% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Mayo Clinic opened a new position in Scilex Holding worth $347K.
- Mayo Clinic's largest Q1 2023 buy was Scilex Holding: 1,209 shares worth $347K.
- Mayo Clinic added most to Exact Sciences in Q1 2023, an estimated $96.2K increase.
- Mayo Clinic's biggest Q1 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $75.5M.
- Mayo Clinic fully exited Sorrento Therapeutics, Inc. in Q1 2023, selling an estimated $267K.
- Mayo Clinic's ten largest holdings make up 100% of its $122M portfolio in Q1 2023.
- Mayo Clinic opened 1 new position and closed 1 in Q1 2023.
- Mayo Clinic's portfolio value fell 35% quarter-over-quarter to $122M.
Based on Mayo Clinic's 13F filing for Q1 2023, filed 5 May 2023.